Well, we've got an eye opening recall to tell you about this morning. There are two eye drops you need to drop the FDA recalling. Doctor burns, eye drops and light eyes, MS M light eye drops. Now, ...
The US Food and Drug Administration (FDA) has cleared Grifols' investigational new drug (IND) application to initiate a Phase II trial of GRF312 Ophthalmic Solution, an immunoglobulin (IG) eye drop, ...
More than 360 million people around the world suffer from dry eye disease, which is characterized by chronically red, scratchy or irritated eyes. blackday - stock.adobe.com Dry eye disease is no ...
Millions of eye drop products have been recalled over concerns they may not be sterile, according to an enforcement report from the U.S. Food and Drug Administration. On March 3, eye care product ...
Please provide your email address to receive an email when new articles are posted on . Orasis Pharmaceuticals has submitted a new drug application to the FDA for CSF-1, its investigational eye drop ...
FARMINGTON HILLS, Mich., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing ...
Add Yahoo as a preferred source to see more of our stories on Google. Eye care products at a CVS Pharmacy. (Jeffrey Greenberg/Education Images/Universal Images Group via Getty Images) U.S. health ...
Nexthera Co. Ltd. has submitted an IND application to the FDA seeking to conduct a phase I/IIa trial with NT-101, a noninvasive eye drop treatment for wet age-related macular degeneration (AMD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results